SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-10-000175
Filing Date
2010-02-19
Accepted
2010-02-19 11:31:42
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCBAM OPPORTUNITY FUND SPV, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT - PRANA BIOTECHNOLOGY LTD. bam_13gaprana.htm SC 13G/A 201202
  Complete submission text file 0000929638-10-000175.txt   203277
Mailing Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052
Business Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052 61-3-9349-4906
PRANA BIOTECHNOLOGY LTD (Subject) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-79901 | Film No.: 10618609
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A